Medical Devices Investors & VC Firms in Europe
346 firms in this list, with a median first check of $550K. 85 of them lead rounds. Generated from verified public data and updated continuously.
EQT Life Sciences
LuxembourgSeed–Late Stage$33M – $66M
30 people
Innovobot
MontrealPre-Seed–Series A$182.5K – $365K
30 people
Catalyst Investments, L.P.
Tel AvivGrowth–Late Stage$1.5M – $5M
30 people
LIFTT
TorinoPre-Seed–Late Stage
33 people
Voima Ventures
HelsinkiPre-Seed–Series B$216K – $3.2M
11 people
Arkin Capital
HerzliyaSeed–Late Stage
28 people
Claret Capital Partners
LondonSeries A–Late Stage
28 people
Beyond Capital Partners
Frankfurt am MainGrowth–Late Stage
24 people
Air Street Capital
St. Peter PortPre-Seed–Growth$500K – $10M
6 people
Essex Woodlands Healthcare Partners
New YorkGrowth–Late Stage$20M – $80M
18 people
Skagerak Capital
KristiansandSeed–Series A$10K – $250K
13 people
VI Partners
AltendorfSeed–Series B$2.2M – $4.5M
15 people
AdBio partners
ParisPre-Seed–Series A
21 people
Epidarex Capital
BethesdaPre-Seed–Series A$2.5M – $6.3M
9 people
MIG Capital AG
MunichSeed–Growth$1.1M – $10.8M
23 people
HealthCap
StockholmSeed–Growth
28 people
Gilde Healthcare
UtrechtSeed–Late Stage$1.1M – $55M
24 people
Hadean Ventures
OsloSeed–Growth
21 people
415 Capital
MunichSeries A–Late Stage$5.4M – $16.2M
14 people
Forepont Capital Partners
New YorkPre-Seed–Late Stage
23 people
TVM Capital
MunichSeed–Late Stage$1.1M – $16.2M
22 people
Asabys Partners
MadridSeed–Growth
16 people
Btomorrow Ventures
LondonSeed–Growth
17 people
Panacea Venture
SingaporePre-Seed–Late Stage
20 people
Related lists
Crypto & Web3 Investors & VC Firms (4538)Investors & VC Firms in United States (4128)Investors & VC Firms in Global (3505)SaaS Investors & VC Firms (3157)Fintech Investors & VC Firms (2971)AI & Machine Learning Investors & VC Firms (2858)Enterprise Software Investors & VC Firms (2712)Healthtech Investors & VC Firms (2708)Investors & VC Firms in Europe (2540)Consumer Investors & VC Firms (2073)
Data sourced from public filings and firms' own websites — see our methodology.























































































